iRhythm Technologies, Inc. (NASDAQ:IRTC) Given Average Rating of “Moderate Buy” by Brokerages

iRhythm Technologies, Inc. (NASDAQ:IRTC) has received an average rating of “Moderate Buy” from the eight ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $131.33.

Several research analysts recently commented on the stock. Oppenheimer raised their price target on shares of iRhythm Technologies from $125.00 to $165.00 in a research note on Friday, August 4th. Citigroup decreased their price target on shares of iRhythm Technologies from $115.00 to $100.00 in a research note on Monday, October 2nd. StockNews.com cut iRhythm Technologies from a “hold” rating to a “sell” rating in a research note on Thursday, October 5th. Morgan Stanley decreased their target price on iRhythm Technologies from $149.00 to $135.00 and set an “overweight” rating for the company in a research report on Wednesday, October 11th. Finally, Needham & Company LLC dropped their price target on iRhythm Technologies from $140.00 to $108.00 and set a “buy” rating on the stock in a research report on Friday, November 3rd.

Institutional Investors Weigh In On iRhythm Technologies

Institutional investors have recently bought and sold shares of the company. Covestor Ltd increased its holdings in shares of iRhythm Technologies by 285.2% during the third quarter. Covestor Ltd now owns 312 shares of the company’s stock valued at $29,000 after acquiring an additional 231 shares in the last quarter. Lazard Asset Management LLC purchased a new position in shares of iRhythm Technologies in the third quarter worth $38,000. Nisa Investment Advisors LLC lifted its stake in shares of iRhythm Technologies by 110.3% during the third quarter. Nisa Investment Advisors LLC now owns 574 shares of the company’s stock worth $54,000 after buying an additional 301 shares during the period. Point72 Hong Kong Ltd purchased a new stake in shares of iRhythm Technologies during the second quarter valued at $85,000. Finally, Captrust Financial Advisors increased its position in shares of iRhythm Technologies by 102.3% in the 2nd quarter. Captrust Financial Advisors now owns 985 shares of the company’s stock valued at $106,000 after acquiring an additional 498 shares during the period.

iRhythm Technologies Stock Performance

IRTC stock opened at $81.60 on Thursday. iRhythm Technologies has a twelve month low of $70.24 and a twelve month high of $140.23. The firm has a market cap of $2.50 billion, a price-to-earnings ratio of -23.58 and a beta of 1.32. The business’s fifty day simple moving average is $84.96 and its two-hundred day simple moving average is $100.98. The company has a quick ratio of 2.16, a current ratio of 2.29 and a debt-to-equity ratio of 0.16.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.